Mesothelioma Organization Applauds Inclusion of $50 million for Cancer Research Program

Share Article

The Mesothelioma Applied Research Foundation (Meso Foundation) applauds Congress for including $50 million in funding for the Peer Reviewed Cancer Research Program, under which mesothelioma is an eligible cancer.

The Meso Foundation is working with our advocacy partners to thank Congress for including this provision, and to ensure that it passes both chambers of Congress

In the latest iteration of its budget bill, Congress included $50 million for the Department of Defense’s (DoD) Peer Reviewed Cancer Research Program (PRCRP). The bill will be voted on in the House on Friday, and in the Senate shortly thereafter.

If the bill does pass, this level of funding will be consistent with funding for fiscal year 2015, which was also set at $50 million. Prior to this, in 2014, the program was awarded only $25 million.

“The Meso Foundation is working with our advocacy partners to thank Congress for including this provision, and to ensure that it passes both chambers of Congress,” said Melinda Kotzian, the chief executive officer for the Mesothelioma Applied Research Foundation.

According to the DoD’s website, the Peer Reviewed Cancer Research Program (PRCRP) was established to support innovative and competitive research in cancers specifically designated by Congress as relevant to military service members and their families. Members of the military are exposed to hazardous environments due to the nature of their service and deployments and, thus, are at risk for the development of different types of cancers.

The Meso Foundation was instrumental in making mesothelioma an eligible topic within the DoD’s research programs. The first ever DoD award for mesothelioma occurred in 2008 when one investigator obtained over $1.3 million for research. A total of $11.96 million has been awarded to mesothelioma research through the Peer Reviewed Medical Research Program and the Peer Reviewed Cancer Research Program, both divisions of the Congressionally Directed Medical Research Program administered by the Department of Defense.

Mesothelioma is a malignant tumor of the lining of the lung, abdomen, or heart known to be caused by exposure to asbestos. With the life expectancy of less than one year after diagnosis, medical experts consider it one of the most aggressive and deadly of all cancers. An estimated one-third of those who develop mesothelioma were exposed while serving in the Navy or working in shipyards. Currently, few treatment options exist. There is no cure.

ABOUT THE MESOTHELIOMA APPLIED RESEARCH FOUNDATION
The Meso Foundation is the only 501(c)(3) nonprofit organization dedicated to eradicating mesothelioma and easing the suffering caused by this cancer. The Meso Foundation actively seeks philanthropic support to fund mesothelioma research; provide patient support services and education; and advocate Congress for increased federal funding for mesothelioma research. The Meso Foundation is the only non-government funder of peer-reviewed scientific research to develop life-saving treatments for this extremely aggressive cancer. To date, the Foundation has awarded over $9 million to research. More information is available at http://www.curemeso.org.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Maja Belamaric
Follow us on
Visit website